A new mRNA vaccine based on the malaria circumsporozoite protein was shown to elicit a robust immune response in mice.
List view / Grid view
Walter Reed Army Institute of Research (WRAIR)
Six antibodies specific to the circumsporozoite protein of the malaria parasite have shown promise as therapeutic interventions, a study has shown.
A genetic analysis of SARS-CoV-2 sequences reveal the virus has mutated minimally since December 2019, suggesting only one vaccine is needed to combat COVID-19.
Researchers in the United States have used particles from the tobacco mosaic virus (TMV) to produce a new much-needed malaria vaccine.
6 July 2016 | By Victoria White, Digital Content Producer
Sanofi Pasteur has signed a Cooperative Research and Development Agreement with the WRAIR on the co-development of a Zika vaccine candidate...